Skip to content

Oral memantine and pain after orthopedic surgery

Comparison the effect of pre-operative oral memantine and placebo on pain following orthopedic surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015101824576N1
Enrollment
110
Registered
2016-06-10
Start date
2015-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients needing orthopedic surgery of the lower limbs below the knee. Injury, poisoning and certain other consequences of external causes

Interventions

Intervention 1: Intervention 1: In the intervention group 20 mg of memantine were administrated one hour before surgery for the patient. Intervention 2: Intervention 2: In the control group placebo we
Treatment - Drugs
Intervention 1: In the intervention group 20 mg of memantine were administrated one hour before surgery for the patient.
Intervention 2: In the control group placebo were administrated (a capsule containing starch inside the shed) one hour before surgery for the patient.

Sponsors

Vice Chancellor for research of Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria including age range between 18 and 60 years, having indications for spinal anesthesia, having surgery of the lower limbs below the knee for bone plaque embedding. Exclusion criteria including any postoperative complication requires surgical intervention, lack of consent to participate in the study, having a history of substance abuse, history of chronic disease such as diabetes, high blood pressure and etc. taking medication, having a mental illness, having known hypersensitivity to the ketamine drug, having mental retardation and loss of consciousness, hemodynamic disorders, bleeding disorders and anemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 30 and 60 minutes, 2, 12 and 24 hours after surgery. Method of measurement: VAS (Visual Analogue Scale) ruler.

Secondary

MeasureTime frame
Consumption of Analgesic amount. Timepoint: 30 and 60 minutes, 2, 12 and 24 hours after surgery. Method of measurement: mg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhalil Souloki

Zahedan University of Medical Sciences

solokikhalil@yahoo.com+98 54 3329 5796

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026